Barrett's esophagus - Diagnosis and management;Barret-Osophagus - Diagnose und management

Internist

Volumn 41, Issue 9, 2000, Pages 802-816

  Ott, R ^a   Lersch, C ^a   Werner, M ^a   Classen, M ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE;

AUTOFLUORESCENCE; BARRETT ESOPHAGUS; CANCER SCREENING; ESOPHAGOSCOPY; HISTOPATHOLOGY; HUMAN; PRECANCER; REVIEW; STOMACH FUNDOPLICATION; TUMOR BIOPSY; ADENOCARCINOMA; CELL TRANSFORMATION; DIFFERENTIAL DIAGNOSIS; ELECTROCOAGULATION; ESOPHAGUS; ESOPHAGUS TUMOR; GASTROESOPHAGEAL REFLUX; GENETIC PREDISPOSITION; GERMANY; PATHOLOGY; PATHOPHYSIOLOGY; PHOTOCHEMOTHERAPY; UNITED STATES;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CELL TRANSFORMATION, NEOPLASTIC; DIAGNOSIS, DIFFERENTIAL; ELECTROCOAGULATION; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; ESOPHAGUS; GASTROESOPHAGEAL REFLUX; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HUMANS; PHOTOCHEMOTHERAPY; UNITED STATES;

EID: 0033826804     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001080050633     Document Type: Review

References (53)

1. Variable pathologic interpretation of columnar lined esophagus by general pathologists in community practice
2. Molecular genetics of neoplastic progression in Barrett's esophagus
3. Chronic peptic ulcer in the esophagus and oesophagitis
4. Adenocarcinoma of the esophagus and Barrett's esophagus. A population-based study
5. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings
6. Barrett's esophagus: Prevalence and size of hiatal hernia
7. Methylenblue selectively stains intestinal metaplasia in Barrett's esophagus
8. Endosocopic laser ablation of Barrett's mucosa followed by Nissen fundoplication: Results of a pilot study
9. The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high grade dysplasia
10. Prospektiver vergleich von autofluoreszenz, farben und video-endoskopie mit stufenbiopsie in der dysplasie-diagnostik beim barrett-osophagus
11. Evaluations of topical gene therapy for head and neck squamous cell carcinoma in an organotypic model
12. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus
13. Reflux disease and Barrett's esophagus
14. Risk factors for dysplasia in patients with Barrett's esophagus. Results from a multicenter consortium
15. Photodynamische Diagnostik (PDD) mit 5-Aminolavulinsaure bei Barrett-Osophagus mit schweren Dysplasien oder Fruhkarzinomen
16. Photodynamic ablation of high-grade dysplasia in Barrett's esophagus by means of 5-aminolevulinic acid
17. Untersuchungen zum stand der diagnostik des Barrett-Osophagus. Eine analyse yon 1000 histologisch diagnostizierten Fallen
18. Barrett's esophagus, dysplasia, and adenocarcinoma
19. Specialized intestinal metaplasia, dysplasia and cancer of the esophagus and esophagogastric junction: Prevalence arid clinical data
20. Early adenocarcinoma in Barrett's esophagus
21. Do proton pump inhibitors induce regression of Barrett's esophagus? A systematic review
22. Screening for specialized columnar epithelium with Methylen blue in patients with Barrett's esophagus and normal controls. Endoscopy
23. Curing helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis
24. Natural history of high grade dysplasia in Barrett's esophagus
25. Barrett's esophagus: Does an antireflux procedure reduce the need for endoscopic surveillance?
26. Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach
27. Much ado about the 'ultrashort' Barrett esophagus? Results from the munich mulitcenter study
28. Photodynamic therapy of Barrett's esophagus: Follow-up in 100 patients
29. The histologic spectrum of Barrett's esophagus
30. Barrett's esophagus: A new look at surveillance based on emerging estimates of cancer risk
31. Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression
32. DDW report New Orleans May 1998: An overview on the endoscopic abstracts
33. Practice guidelines on the diagnosis, surveillance and therapy of Barrett's esophagus
34. Adenocarcinoma arising in tongues or short segments of Barrett's esophagus
35. High grade dysplasia is not an indication for surgery in patients with Barrett's esophagus
36. Biopsy differential diagnosis of gastroesophageal reflux
37. Dysplasia in short segments Barrett's esophagus - A prospective 3 year follow-up
38. Long term reversal of patients with Barrett's esophagus with multipolar electrocoagulation (MPEC) and high dose omeprazole
39. Barrett's Esophagus
40. Prevalence of meta-plasia at the gastro-esophageal juntion
41. The columnar-lined esophagus, intestinal metaplasia and Norman Barrett
42. Short and ultrashort Barrett's esophagus - What does ist mean?
43. Can endoscopists locate the lower esophageal sphincter (LES) accurately?
44. Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus
45. Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma
46. Pradisponiert helicobacter pylori bei patienten mit Barrett-Mukosa zu Dysplasie und Adenokarzinom des osophagus?
47. The molecular pathology of Barrett's esophagus
48. Adenocarcinoma of the oesophagus
49. Prospective evaluation of intestinal metplasia and dysplasia within the cardia of patients with Barrett's esophagus
50. Barrett's esophagus: A prevalent, occult complication of gastroesophageal reflux disease
51. Cardiac mucosa - Prevalence and associations with intestinal metaplasia
52. Genetic alterations in Barrett's esophagus and adenocarcinomas of the esophagus and the esophagogastric junction region